Acutaas Chemicals Ltd’s board approved a capital expenditure plan of up to ₹212 crore to establish manufacturing facilities for electronic grade chemicals in Gujarat. The decision was taken during the board meeting held on August 22, 2026.

The company also adopted its annual report for the financial year 2025-26 and scheduled its 19th Annual General Meeting (AGM) for September 24, 2026. The AGM will be conducted through video conferencing or other audio-visual means.

Capital Expenditure Details

The proposed investment aims to set up greenfield or brownfield manufacturing plants in Gujarat. The project targets a production capacity of up to 81,000 metric tonnes per annum for new electronic grade chemicals. Acutaas Chemicals plans to complete this capacity addition by the end of FY27-28.

The company currently has no existing capacity for these specific products. Financing for the ₹212 crore outlay will come from internal accruals, bank finance, or other permissible methods. The expansion may be undertaken by the parent company or through any of its subsidiaries registered in India.

Board and Governance Updates

The board recommended the re-appointment of Mr. Ram Mohan Lokhande as Whole Time Director and Mrs. Anita Bandyopadhyay as Non-Executive Independent Director. Both appointments are for five-year terms starting February 8, 2027, subject to shareholder approval at the upcoming AGM.

Mr. Lokhande brings extensive experience in Active Pharmaceutical Ingredients (API) manufacturing and specialty chemicals. Mrs. Bandyopadhyay is a distinguished human resources professional with expertise in strategic HR management and organizational design.

Additionally, the board approved extending the benefits of the Ami Organics Employees Stock Option Scheme 2023 to eligible employees of the company’s Indian subsidiaries. This proposal also requires shareholder approval at the AGM.

Acutaas Chemicals received approval for an incentive package valued at ₹119.12 crore under the Electronics Components Manufacturing Scheme (ECMS). The approval was issued by Engineers India Limited, acting as Project Management Agency (PMA) on behalf of the Ministry of Electronics and Information Technology (MeitY). The scheme covers up to 25% of eligible investment on a total project investment of ₹256.47 crore for the electrolyte additives manufacturing business located at Jhagadia, Gujarat, over a benefit period extending to FY 2030-31. This is a government subsidy notification, not a commercial work order or sales contract.

Incentive structure

The key parameters of the ECMS approval are summarised below:

Order in financial context

This filing does not represent a confirmed revenue-generating order. As a result, it does not add to the company's order book or backlog. The total disclosed order book remains at zero, representing 0.00 quarters of average quarterly revenue coverage. The book-to-bill ratio is effectively non-existent as there is no active order inflow to compare against trailing twelve-month revenue of ₹1,489.3 crore. The ₹119.12 crore figure represents a potential reduction in net capital expenditure rather than a top-line revenue driver.

Company order track record

No previous order disclosures were found for Acutaas Chemicals in the last three fiscal quarters. The company operates in a sector where revenue is typically recognised through product sales rather than long-term project contracts, explaining the absence of traditional order book filings. Consequently, there is no historical order inflow data to benchmark against this incentive approval.

Execution and revenue quality

The company exhibits strong margin quality and consistent profitability. Operating profit margins expanded significantly, reaching 42.41% in Q4FY26 before settling at 34.30% in Q1FY27. Net profit generation remains robust, with ₹75.00 crore reported in the latest quarter.

Revenue growth

Acutaas Chemicals has sustained strong operational performance, with annual revenue growing from ₹1,023.80 crore in FY25 to ₹1,339.37 crore in FY26, representing YoY growth of +30.8% based on the latest annual data. This growth trajectory aligns with the company's expanding manufacturing capabilities, which are now further supported by the newly approved government incentives.

Working capital and execution capacity

The balance sheet is highly liquid with a current ratio of 3.82x, providing ample working capital buffer. Total liabilities/equity stands at a conservative 0.20x, indicating low leverage. Operating cashflow was ₹118.30 crore in FY25 against capex of ₹194.60 crore, resulting in negative free cashflow of ₹76.30 crore. The ₹119.12 crore ECMS incentive will be critical in funding future capital expenditures without straining the cash conversion cycle.

What to watch

• Incentive disbursement: Monitor the actual disbursement schedule of the ECMS funds. These are typically released in tranches linked to eligible investment milestones, not upfront.
• Capex execution: Track whether the Jhagadia facility expansion proceeds as planned. The incentive is tied to specific investment thresholds that must be met to unlock the full benefit.
• Margin sustainability: Watch if the high OPM levels (>34%) can be maintained as new capacity comes online and potentially faces pricing pressure.
• Cash flow conversion: Given the history of negative free cashflow, observe if the subsidy helps turn free cashflow positive in upcoming quarters.

Key observations

• Incentive vs order: This filing is a government subsidy approval, not a commercial order. It reduces net capex but does not generate direct revenue or add to the order book.
• Valuation check (as of August 18, 2026): P/E of 67.7x against ROCE of 16.51%. Valuation was pricing in execution improvement not yet visible in return ratios. (P/E is price-derived and will change; ROCE is from audited financials)
• Cash conversion: Operating cashflow of ₹118.30 crore in FY25 was insufficient to cover capex of ₹194.60 crore, resulting in negative free cashflow. The new incentive may alleviate this pressure.